Clinical TrialsSearch results
Number of results: 916
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- MASTERPIECE study
- Patients who undergo colonoscopy
- Uraoka Toshio
- 2022-04-20
Other
- Study on the efficacy of octreotide acetate for cancer-related bowel obstruction
- cancer-related bowel obstruction
- University of Tsukuba
- 2006-11-14
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Other
- A comparison of peginterferon ribavirin combination therapies for chronic hepatitis C
- chronic hepatitis C with high viral load (>100KIU/ml) and serogroup I
- University of Tokyo Department of Gastroenterology, Faculty of Medicine
- 2007-11-17
Other
- Discontinuation of infliximab therapy after acquisition of low disease activity by infliximab in rheumatoid arthritis study: RRR (remission induction by remicade) study
- rheumatoid arthritis
- University of Occupational & Environmental Health, Japan
- 2009-06-23
No Longer Recruiting
- A study in healthy Japanese and Chinese men to test how well different doses of BI 706321 are tolerated
- Crohns disease
- Umezu Masafumi
- 2021-10-28
Completed
- Trastuzumab deruxtecan for subjects with HER2 mutated metastatic NSCLC
- Non-Small Cell Lung Cancer
- Ueno Shizuko
- 2023-01-30
Other
- CUARTET Study
- Metastatic Castration-sensitive Prostate Cancer
- Uemura Hirotsugu
- 2020-10-09
Other
- A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreated, High-intermediate and High-risk Patients With Newly-diagnosed Diffuse Large B-cell Lymphoma (DLBCL)
- Diffuse Large B-cell Lymphoma
- Ueda Eiji
- 2022-06-24
Completed
- A phase 2 study of osimertinib in elderly patients with non-small-cell lung cancer
- advanced / recurrent non-small cell lung cancer (NSCLC)
- Uchino Junji
- 2018-09-03